Medical Care

Global Chronic Heart Failure Treatment Market Research Report 2025

The global market for Chronic Heart Failure Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Heart Failure Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Heart Failure Treatment.
The Chronic Heart Failure Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Heart Failure Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Heart Failure Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Abbott
Johnson & Johnson
Merck
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Pfizer
GlaxoSmithKline plc
Novartis International AG
Biovail Corporation
Bristol-Myers Squibb Company
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Segment by Type
ICDs
VADs
Drugs
Others
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Heart Failure Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Heart Failure Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ICDs
1.2.3 VADs
1.2.4 Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Heart Failure Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Heart Failure Treatment Market Perspective (2020-2031)
2.2 Global Chronic Heart Failure Treatment Growth Trends by Region
2.2.1 Global Chronic Heart Failure Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Heart Failure Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Heart Failure Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Heart Failure Treatment Market Dynamics
2.3.1 Chronic Heart Failure Treatment Industry Trends
2.3.2 Chronic Heart Failure Treatment Market Drivers
2.3.3 Chronic Heart Failure Treatment Market Challenges
2.3.4 Chronic Heart Failure Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Heart Failure Treatment Players by Revenue
3.1.1 Global Top Chronic Heart Failure Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Heart Failure Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Heart Failure Treatment Revenue
3.4 Global Chronic Heart Failure Treatment Market Concentration Ratio
3.4.1 Global Chronic Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Heart Failure Treatment Revenue in 2024
3.5 Global Key Players of Chronic Heart Failure Treatment Head office and Area Served
3.6 Global Key Players of Chronic Heart Failure Treatment, Product and Application
3.7 Global Key Players of Chronic Heart Failure Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Heart Failure Treatment Breakdown Data by Type
4.1 Global Chronic Heart Failure Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Heart Failure Treatment Breakdown Data by Application
5.1 Global Chronic Heart Failure Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Heart Failure Treatment Market Size (2020-2031)
6.2 North America Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Heart Failure Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Heart Failure Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Heart Failure Treatment Market Size (2020-2031)
7.2 Europe Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Heart Failure Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Heart Failure Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Heart Failure Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Heart Failure Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Heart Failure Treatment Market Size (2020-2031)
9.2 Latin America Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Heart Failure Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Heart Failure Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Heart Failure Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Heart Failure Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Chronic Heart Failure Treatment Introduction
11.1.4 Medtronic Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Chronic Heart Failure Treatment Introduction
11.2.4 Abbott Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Chronic Heart Failure Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Heart Failure Treatment Introduction
11.4.4 Merck Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Stanley Pharmaceuticals
11.5.1 Stanley Pharmaceuticals Company Details
11.5.2 Stanley Pharmaceuticals Business Overview
11.5.3 Stanley Pharmaceuticals Chronic Heart Failure Treatment Introduction
11.5.4 Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.5.5 Stanley Pharmaceuticals Recent Development
11.6 New Haven Pharmaceuticals, Inc.
11.6.1 New Haven Pharmaceuticals, Inc. Company Details
11.6.2 New Haven Pharmaceuticals, Inc. Business Overview
11.6.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Introduction
11.6.4 New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.6.5 New Haven Pharmaceuticals, Inc. Recent Development
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Details
11.7.2 Boston Scientific Corporation Business Overview
11.7.3 Boston Scientific Corporation Chronic Heart Failure Treatment Introduction
11.7.4 Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.7.5 Boston Scientific Corporation Recent Development
11.8 HeartWare
11.8.1 HeartWare Company Details
11.8.2 HeartWare Business Overview
11.8.3 HeartWare Chronic Heart Failure Treatment Introduction
11.8.4 HeartWare Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.8.5 HeartWare Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Chronic Heart Failure Treatment Introduction
11.9.4 Pfizer Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 GlaxoSmithKline plc
11.10.1 GlaxoSmithKline plc Company Details
11.10.2 GlaxoSmithKline plc Business Overview
11.10.3 GlaxoSmithKline plc Chronic Heart Failure Treatment Introduction
11.10.4 GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.10.5 GlaxoSmithKline plc Recent Development
11.11 Novartis International AG
11.11.1 Novartis International AG Company Details
11.11.2 Novartis International AG Business Overview
11.11.3 Novartis International AG Chronic Heart Failure Treatment Introduction
11.11.4 Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.11.5 Novartis International AG Recent Development
11.12 Biovail Corporation
11.12.1 Biovail Corporation Company Details
11.12.2 Biovail Corporation Business Overview
11.12.3 Biovail Corporation Chronic Heart Failure Treatment Introduction
11.12.4 Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.12.5 Biovail Corporation Recent Development
11.13 Bristol-Myers Squibb Company
11.13.1 Bristol-Myers Squibb Company Company Details
11.13.2 Bristol-Myers Squibb Company Business Overview
11.13.3 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Introduction
11.13.4 Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.13.5 Bristol-Myers Squibb Company Recent Development
11.14 Abiomed
11.14.1 Abiomed Company Details
11.14.2 Abiomed Business Overview
11.14.3 Abiomed Chronic Heart Failure Treatment Introduction
11.14.4 Abiomed Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.14.5 Abiomed Recent Development
11.15 Symplmed Pharmaceuticals
11.15.1 Symplmed Pharmaceuticals Company Details
11.15.2 Symplmed Pharmaceuticals Business Overview
11.15.3 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Introduction
11.15.4 Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.15.5 Symplmed Pharmaceuticals Recent Development
11.16 Berlin Heart GmbH
11.16.1 Berlin Heart GmbH Company Details
11.16.2 Berlin Heart GmbH Business Overview
11.16.3 Berlin Heart GmbH Chronic Heart Failure Treatment Introduction
11.16.4 Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.16.5 Berlin Heart GmbH Recent Development
11.17 ReliantHeart, Inc.
11.17.1 ReliantHeart, Inc. Company Details
11.17.2 ReliantHeart, Inc. Business Overview
11.17.3 ReliantHeart, Inc. Chronic Heart Failure Treatment Introduction
11.17.4 ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.17.5 ReliantHeart, Inc. Recent Development
11.18 Cardiokinetix
11.18.1 Cardiokinetix Company Details
11.18.2 Cardiokinetix Business Overview
11.18.3 Cardiokinetix Chronic Heart Failure Treatment Introduction
11.18.4 Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.18.5 Cardiokinetix Recent Development
11.19 Biotronik
11.19.1 Biotronik Company Details
11.19.2 Biotronik Business Overview
11.19.3 Biotronik Chronic Heart Failure Treatment Introduction
11.19.4 Biotronik Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.19.5 Biotronik Recent Development
11.20 Jarvik Heart
11.20.1 Jarvik Heart Company Details
11.20.2 Jarvik Heart Business Overview
11.20.3 Jarvik Heart Chronic Heart Failure Treatment Introduction
11.20.4 Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2020-2025)
11.20.5 Jarvik Heart Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Heart Failure Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ICDs
Table 3. Key Players of VADs
Table 4. Key Players of Drugs
Table 5. Key Players of Others
Table 6. Global Chronic Heart Failure Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Chronic Heart Failure Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Chronic Heart Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Chronic Heart Failure Treatment Market Share by Region (2020-2025)
Table 10. Global Chronic Heart Failure Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Chronic Heart Failure Treatment Market Share by Region (2026-2031)
Table 12. Chronic Heart Failure Treatment Market Trends
Table 13. Chronic Heart Failure Treatment Market Drivers
Table 14. Chronic Heart Failure Treatment Market Challenges
Table 15. Chronic Heart Failure Treatment Market Restraints
Table 16. Global Chronic Heart Failure Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Chronic Heart Failure Treatment Market Share by Players (2020-2025)
Table 18. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2024)
Table 19. Ranking of Global Top Chronic Heart Failure Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Chronic Heart Failure Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Chronic Heart Failure Treatment, Headquarters and Area Served
Table 22. Global Key Players of Chronic Heart Failure Treatment, Product and Application
Table 23. Global Key Players of Chronic Heart Failure Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Heart Failure Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Chronic Heart Failure Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Chronic Heart Failure Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Chronic Heart Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Medtronic Company Details
Table 49. Medtronic Business Overview
Table 50. Medtronic Chronic Heart Failure Treatment Product
Table 51. Medtronic Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 52. Medtronic Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott Chronic Heart Failure Treatment Product
Table 56. Abbott Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Chronic Heart Failure Treatment Product
Table 61. Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Chronic Heart Failure Treatment Product
Table 66. Merck Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Stanley Pharmaceuticals Company Details
Table 69. Stanley Pharmaceuticals Business Overview
Table 70. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product
Table 71. Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 72. Stanley Pharmaceuticals Recent Development
Table 73. New Haven Pharmaceuticals, Inc. Company Details
Table 74. New Haven Pharmaceuticals, Inc. Business Overview
Table 75. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product
Table 76. New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 77. New Haven Pharmaceuticals, Inc. Recent Development
Table 78. Boston Scientific Corporation Company Details
Table 79. Boston Scientific Corporation Business Overview
Table 80. Boston Scientific Corporation Chronic Heart Failure Treatment Product
Table 81. Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 82. Boston Scientific Corporation Recent Development
Table 83. HeartWare Company Details
Table 84. HeartWare Business Overview
Table 85. HeartWare Chronic Heart Failure Treatment Product
Table 86. HeartWare Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 87. HeartWare Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Chronic Heart Failure Treatment Product
Table 91. Pfizer Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. GlaxoSmithKline plc Company Details
Table 94. GlaxoSmithKline plc Business Overview
Table 95. GlaxoSmithKline plc Chronic Heart Failure Treatment Product
Table 96. GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 97. GlaxoSmithKline plc Recent Development
Table 98. Novartis International AG Company Details
Table 99. Novartis International AG Business Overview
Table 100. Novartis International AG Chronic Heart Failure Treatment Product
Table 101. Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 102. Novartis International AG Recent Development
Table 103. Biovail Corporation Company Details
Table 104. Biovail Corporation Business Overview
Table 105. Biovail Corporation Chronic Heart Failure Treatment Product
Table 106. Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 107. Biovail Corporation Recent Development
Table 108. Bristol-Myers Squibb Company Company Details
Table 109. Bristol-Myers Squibb Company Business Overview
Table 110. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product
Table 111. Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 112. Bristol-Myers Squibb Company Recent Development
Table 113. Abiomed Company Details
Table 114. Abiomed Business Overview
Table 115. Abiomed Chronic Heart Failure Treatment Product
Table 116. Abiomed Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 117. Abiomed Recent Development
Table 118. Symplmed Pharmaceuticals Company Details
Table 119. Symplmed Pharmaceuticals Business Overview
Table 120. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product
Table 121. Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 122. Symplmed Pharmaceuticals Recent Development
Table 123. Berlin Heart GmbH Company Details
Table 124. Berlin Heart GmbH Business Overview
Table 125. Berlin Heart GmbH Chronic Heart Failure Treatment Product
Table 126. Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 127. Berlin Heart GmbH Recent Development
Table 128. ReliantHeart, Inc. Company Details
Table 129. ReliantHeart, Inc. Business Overview
Table 130. ReliantHeart, Inc. Chronic Heart Failure Treatment Product
Table 131. ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 132. ReliantHeart, Inc. Recent Development
Table 133. Cardiokinetix Company Details
Table 134. Cardiokinetix Business Overview
Table 135. Cardiokinetix Chronic Heart Failure Treatment Product
Table 136. Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 137. Cardiokinetix Recent Development
Table 138. Biotronik Company Details
Table 139. Biotronik Business Overview
Table 140. Biotronik Chronic Heart Failure Treatment Product
Table 141. Biotronik Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 142. Biotronik Recent Development
Table 143. Jarvik Heart Company Details
Table 144. Jarvik Heart Business Overview
Table 145. Jarvik Heart Chronic Heart Failure Treatment Product
Table 146. Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2020-2025) & (US$ Million)
Table 147. Jarvik Heart Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Chronic Heart Failure Treatment Picture
Figure 2. Global Chronic Heart Failure Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Heart Failure Treatment Market Share by Type: 2024 VS 2031
Figure 4. ICDs Features
Figure 5. VADs Features
Figure 6. Drugs Features
Figure 7. Others Features
Figure 8. Global Chronic Heart Failure Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Chronic Heart Failure Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Household Case Studies
Figure 13. Others Case Studies
Figure 14. Chronic Heart Failure Treatment Report Years Considered
Figure 15. Global Chronic Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Chronic Heart Failure Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Chronic Heart Failure Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Chronic Heart Failure Treatment Market Share by Players in 2024
Figure 19. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Chronic Heart Failure Treatment Revenue in 2024
Figure 21. North America Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Chronic Heart Failure Treatment Market Share by Country (2020-2031)
Figure 23. United States Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Chronic Heart Failure Treatment Market Share by Country (2020-2031)
Figure 27. Germany Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Chronic Heart Failure Treatment Market Share by Region (2020-2031)
Figure 35. China Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Chronic Heart Failure Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Chronic Heart Failure Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Chronic Heart Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Medtronic Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 51. Abbott Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 54. Stanley Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 55. New Haven Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 56. Boston Scientific Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 57. HeartWare Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 60. Novartis International AG Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 61. Biovail Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 63. Abiomed Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 64. Symplmed Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 65. Berlin Heart GmbH Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 66. ReliantHeart, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 67. Cardiokinetix Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 68. Biotronik Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 69. Jarvik Heart Revenue Growth Rate in Chronic Heart Failure Treatment Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies